Early-Stage Breast Carcinoma

Known as: early-stage breast cancer 
Breast carcinoma that has not spread beyond the breast and the axillary lymph nodes.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
PURPOSE Prognostic and predictive factors are well established in early-stage breast cancer, but less is known about which… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Older women with breast cancer are underrepresented in clinical trials, and data on the effects of adjuvant… (More)
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Little data exist on whether efficacy benefits or side-effects persist after 5 years of adjuvant treatment with an… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in advanced breast cancer that… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND In hormone-dependent breast cancer, five years of postoperative tamoxifen therapy--but not tamoxifen therapy of longer… (More)
  • table 1
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE Insulin, a member of a family of growth factors that includes insulin-like growth factor (IGF)-I and IGF-II, exerts… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND We analyzed the use of alternative medicine by women who had received standard therapy for early-stage breast cancer… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
BACKGROUND Breast-conservation therapy for early-stage breast cancer is now an accepted treatment, but there is still controversy… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Axillary lymph node status has been the most important prognostic factor in operable breast carcinoma, but it does not… (More)
Is this relevant?